An observational study in Cognitive Impairment, Dementia and Hearing Impairment, sponsored by Tarumanagara University. Status unknown at 1 site in Indonesia. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-13.
Sponsored by Tarumanagara University · Observational
This study aims to explore the determinants of cognitive impairment among Indonesian geriatrics in an Old Age Home.
Elderly patients (≥ 60 years of age) are enrolled in this study. The inclusion criteria are patients which have consented to take part in the study.
Data such as age, ethnic, education, BMI, waist and hip circumference, blood pressure, hearing impairment, vision impairment, depression, sleep disorder, mobility, hemoglobin levels, glycemic and lipid profile, as well as comorbidities and drugs used were collected from the patients' medical records, laboratory tests and through examination by trained examiners.
Cognition was determined through a combination of several psychiatric examinations using validated instruments namely - MiniCog, Clock Drawing Test, Three Word Recall, Alzheimer's Disease-8 Indonesia (AD-8 INA) Questionnaire and Short Portable Mental Status Questionnaire (SPMSQ).
3,872 studies on the registry are indexed under Cognitive Dysfunction; 1,119 are open to participants now.
This study's planned enrollment of 80 is below the median of 150 across 997 observational studies indexed under Cognitive Dysfunction.
Browse Cognitive Dysfunction studies →Tarumanagara University is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Elderly patients (≥ 60 years of age) currently under the care of an Indonesian Old Age Home.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
MiniCog
Based on psychiatric examination using the Indonesian MiniCog Questionnaire to determine patient's cognitive status. A MiniCog result below 5 implies mild cognitive impairment, while a result below 3 implies dementia.
Time frame: Through study completion, an average of 6 months
Clock Drawing Test (CDT)
Based on psychiatric examination using the Indonesian Clock Drawing Test to determine patient's cognitive status. A Clock Drawing Test score below 4 implies mild cognitive impairment.
Time frame: Through study completion, an average of 6 months
Three Word Recall
Based on psychiatric examination using the Indonesian Three Word Recall Test to determine patient's cognitive status with resulting score from 0-3. Zero means no words can be recalled by the patient.
Time frame: Through study completion, an average of 6 months
Alzheimer Disease-8 Indonesia Questionnaire (AD-8 INA)
Based on interviews with caretakers using the AD-8 INA Questionnaire to determine patient's cognitive status. An AD-8 INA score of 2 or more implies mild cognitive impairment.
Time frame: Through study completion, an average of 6 months
Short Portable Mental Status Questionnaire (SPMSQ)
Based on psychiatric examination using the Indonesian SPMSQ to determine patient's cognitive status. An SPMSQ test in which the patient demonstrated more than 3 mistakes implies mild cognitive impairment, whereas a mistake of greater than 8 implies dementia.
Time frame: Through study completion, an average of 6 months
Hearing Impairment
Based on physical examination using the Whispered Sound Test from 6 meters and tuning fork test as well as history of hearing impairment from medical records.
Time frame: Through study completion, an average of 6 months
Vision Impairment
Based on physical examination using the Snellen Chart and history of vision impairment from medical records.
Time frame: Through study completion, an average of 6 months
Diabetes
Based on glycemic profile results and history of diabetes from medical records. Patients are classified as diabetic in accordance to the Indonesian Society of Endocrinology and American Diabetic Association criteria.
Time frame: Through study completion, an average of 6 months
Mobility
Based on physical examination, Indonesian Validated Lequesne Index, Barthel Acitivities of Daily Living (ADL), Instrumental ADL and history of arthritis or other pathologies affecting mobility from medical records.
Time frame: Through study completion, an average of 6 months
Depression
Based on psychiatric examination, Indonesian Validated Geriatric Depression Scale and Medical Records. A score of 5-9 implies a likelihood of depression, while a score of greater than 10 implies depression.
Time frame: Through study completion, an average of 6 months
Sleep Disorder
Based on psychiatric examination, Indonesian Validated Insomnia Severity Index and Medical Records. A score of 8-14 implies mild insomnia, 15-21 intermediate insomnia and 22-28 severe insomnia.
Time frame: Through study completion, an average of 6 months
Hypertension
Based on blood pressure results and history of hypertension from medical records.
Time frame: Through study completion, an average of 6 months
Dyslipidemia
Based on lipid profile results and history of dyslipidemia from medical records.
Time frame: Through study completion, an average of 6 months
Anemia
Based on hemoglobin results.
Time frame: Through study completion, an average of 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2017 (actual). Primary completion is estimated for Dec 2018, 16 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tarumanagara University